Related Experiment Video
Updated: Feb 18, 2026

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
[A series of 20 cases of endogenous endophthalmitis]
1Service d'ophtalmologie, hopital Pierre-Paul-Riquet, centre hospitalo-universitaire de Toulouse, 1, place du Dr-Joseph-Baylac, 31300 Toulouse, France.
Background:
The purpose of this case series was to evaluate both the visual and systemic prognosis of patients with endogenous endophthalmitis.
Material And Methods:
We reported a series of 20 cases of endogenous endophthalmitis occurring between 2012 and 2015 at the university medical center in Toulouse.
Results:
The mean age was 67 (±43.3) years with a male predominance (n=11). The site of entry was found in 14 cases (87.5%). In 11 cases (69%), the causative agent was a bacterium; a fungal infection was found in five cases. Visual acuity after maximal medical and surgical treatment was limited to "no light perception" in 7 cases (35%), "hand motion" in 2 cases (10%), "finger counting" in 3 cases (15%) and 10/10 in 2 cases (10%). One case had no final data. The main site of entry was found to be associated endocarditis (n=7), central venous line or venipuncture (n=6). The main local complications were retinal detachment (n=6), cataract (n=5) and choroidal neovascularization secondary to scarring (n=2).
Conclusions:
Endogenous endophthalmitis is associated with poor visual prognosis. It is also often associated with systemic complications that may be life-threatening.
Related Concept Videos
Endocarditis I: Introduction
Glaucoma: Overview
Endocarditis II: Clinical Features of Infective Endocarditis
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

